sur Abrdn U.S. Closed-End Funds (NASDAQ:ACP)
Abrdn Life Sciences Investors (HQL) Announces Results of Annual Meeting of Shareholders
PHILADELPHIA, PA / ACCESSWIRE / June 26, 2024 / abrdn Life Sciences Investors ("HQL") disclosed today the outcomes of its Annual Meeting of Shareholders held on June 25, 2024. As of April 1, 2024, HQL had 27,350,517 outstanding shares of common stock, with 87.84% of these shares being voted, representing a quorum.
Shareholders approved the election of two Class B Trustees until the 2027 Annual Meeting. Stephen Bird received 20,269,963 votes (84.4%), while Jeffrey Bailey garnered 19,670,734 votes (81.9%). Votes against or withheld were 3,753,701 (15.6%) for Bird and 4,352,930 (18.1%) for Bailey.
Additionally, a shareholder proposal relating to the annual terms of trustees was opposed. The votes were 6,891,241 (41.6%) in favor, 9,133,348 (55.1%) against or withheld, with 533,327 (3.3%) abstentions.
R. P.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Abrdn U.S. Closed-End Funds